Pharmacology Lore
Order Summary
- $5.99
Venture into the bacterial factory's dark back room with Dossier 08. Here you’ll encounter the Rogue 50S Agents: Clindamycin, Linezolid, and Chloramphenicol.
Instead of dry lists, discover exactly how each sabotages a unique step of the protein synthesis assembly line — from Linezolid blocking initiation to Chloramphenicol halting peptidyl transferase.
Master their deadly baggage: Clindamycin’s notorious link to C. difficile and the critical D-test, Linezolid’s MAO-inhibitor effects that risk serotonin syndrome, and Chloramphenicol’s rare but serious risks of aplastic anemia and gray baby syndrome.
Designed for clinicians and pharmacology enthusiasts, this briefing turns complex therapeutics into a gripping tactical narrative so you can confidently master these high-risk agents.
Entitlements
Order Summary
Dossier 08: The Rogue 50S Agents — Back-Room Saboteurs
$5.99Venture into the bacterial factory's dark back room with Dossier 08. Here you’ll encounter the Rogue 50S Agents: Clindamycin, Linezolid, and Chloramphenicol.
Instead of dry lists, discover exactly how each sabotages a unique step of the protein synthesis assembly line — from Linezolid blocking initiation to Chloramphenicol halting peptidyl transferase.
Master their deadly baggage: Clindamycin’s notorious link to C. difficile and the critical D-test, Linezolid’s MAO-inhibitor effects that risk serotonin syndrome, and Chloramphenicol’s rare but serious risks of aplastic anemia and gray baby syndrome.
Designed for clinicians and pharmacology enthusiasts, this briefing turns complex therapeutics into a gripping tactical narrative so you can confidently master these high-risk agents.
Entitlements